Sonoma Pharmaceuticals, Inc. - 8-K Filing
Sonoma Pharmaceuticals adopted a new Section 382 rights agreement on October 6, 2026, replacing its expiring 2016 agreement and amending preferred stock terms to protect net operating loss carryforwards. (Items: 1.01 Entry into a Material Definitive Agreement, 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 9.01 Financial Statements and Exhibits)
Tickers: $SNOA